You are here: Home » Companies » Q&A
Business Standard

We are researching two candidates for Covid vaccines: Serum Institute CEO

In an e-mail interview with Sohini Das, Adar Poonawalla, chief executive officer, Serum Institute of India, says the firm is not raising additional capital through private equity

Topics
Serum Institute of India | Coronavirus Vaccine | Indian pharma companies

Sohini Das  |  Mumbai 

Adar Poonawalla, CEO, Serum Institute
It will take two-three years to get the world’s population vaccinated, said Adar Poonawalla, CEO, Serum Institute

Pune-headquartered (SII), the world’s largest vaccine maker by quantity, has been in the spotlight, having committed itself to supplying 3.2 billion doses of the Covid-19 vaccine. This is more than double the company’s FY20 production of 1.5 billion doses. Apart from global agencies like Geneva-based Gavi (earlier called Global Alliance for Vaccines and Immunisation) procuring from SII, the Indian vaccination programme too will bank on it. In an e-mail interview with Sohini Das, Adar Poonawalla, chief executive officer, Serum Institute of India, says the firm is not raising additional capital through private equity. SII is researching two new coronavirus vaccines on its own, he adds.

TO READ THE FULL STORY, SUBSCRIBE NOW NOW AT JUST RS 249 A MONTH.

SUBSCRIBE TO INSIGHTS

What you get on Business Standard Premium?

  • icon Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • icon Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • icon Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
  • icon Pick your 5 favourite companies, get a daily email with all news updates on them.
  • icon 26 years of website archives.
  • icon Preferential invites to Business Standard events.

OR

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, December 25 2020. 06:10 IST
RECOMMENDED FOR YOU
.